Article info
Commentary
General medicine
There may be a role for addition of rivaroxaban to aspirin in patients with stable coronary artery disease
- Correspondence to Dr Amitava Banerjee, Farr Institute of Health Informatics, University College London, London WC1E 6BT, UK; ami.banerjee{at}ucl.ac.uk
Citation
There may be a role for addition of rivaroxaban to aspirin in patients with stable coronary artery disease
Publication history
- Accepted July 28, 2018
- First published August 28, 2018.
Online issue publication
March 25, 2019
Article Versions
- Previous version (28 August 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.